跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 691 条关于
“STUGERON FORTE”
全部
691
临床试验
506
药物
52
机构
25
资讯
108
去年
Dr. Reddy's Laboratories Acquires Johnson & Johnson's STUGERON Brand for $50.5 Million to Expand CNS Portfolio
2个月前
Forte Biosciences' FB102 Demonstrates Statistically Significant Efficacy in Phase 1b Vitiligo Trial
4年前
FORE Biotherapeutics Highlights Recent Pipeline Achievements and Strategic Objectives for 2025
5个月前
FORE Biotherapeutics Receives First-Ever Breakthrough Therapy Designation for High-Grade Glioma Targeted Therapy
去年
FORE Biotherapeutics Secures $38 Million in Series D-2 Financing to Advance Plixorafenib Clinical Trials
4个月前
J&J's Ottava Robotic System Meets Primary Endpoints in Gastric Bypass Surgery Trial
去年
FORE Biotherapeutics Advances Plixorafenib in BRAF-Driven Tumors, Eyes Potential FDA Submission
去年
FORE Biotherapeutics Reports Durable Clinical Benefit with Plixorafenib in BRAF-Altered Thyroid Cancers
上个月
QC Ware and IonQ Demonstrate High-Precision Hybrid Quantum Workflow for Drug Discovery
去年
IonQ Achieves 20-Fold Speedup in Drug Discovery Simulations Through Quantum-Classical Hybrid Computing
第 1 页,共 11 页
上一页
下一页